Polymer-coated nanoparticles to promote drug delivery to the brain
Treating diseases such as Alzheimer's or Parkinson's is a challenge because drugs have to be able to cross the blood–brain barrier. As a result, the doses administered must be high and only a small fraction reaches the ...